Page last updated: 2024-08-26

11-ketotestosterone and Polycystic Ovarian Syndrome

11-ketotestosterone has been researched along with Polycystic Ovarian Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlt, W; Jenkinson, C; Kempegowda, P; O'Reilly, MW; Quanson, JL; Storbeck, KH; Taylor, AE1
Auchus, RJ; Turcu, AF1

Other Studies

2 other study(ies) available for 11-ketotestosterone and Polycystic Ovarian Syndrome

ArticleYear
11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
    The Journal of clinical endocrinology and metabolism, 2017, 03-01, Volume: 102, Issue:3

    Topics: Adult; Androgens; Androstenedione; Androstenes; Blood Glucose; Case-Control Studies; Chromatography, Liquid; Dehydroepiandrosterone; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxytestosterones; Hyperandrogenism; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Tandem Mass Spectrometry; Testosterone; Young Adult

2017
Clinical significance of 11-oxygenated androgens.
    Current opinion in endocrinology, diabetes, and obesity, 2017, Volume: 24, Issue:3

    Topics: Adrenal Hyperplasia, Congenital; Biomarkers; Diagnostic Techniques, Endocrine; Female; Humans; Male; Patient-Centered Care; Polycystic Ovary Syndrome; Precision Medicine; Predictive Value of Tests; Prostatic Neoplasms; Testosterone

2017